Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Testing Residue Levels After Cleaning – V 2.0

Posted on By

SOP for Testing Residue Levels After Cleaning – V 2.0

Procedure for Testing Residue Levels After Cleaning

Department Quality Control (QC)/Quality Assurance (QA)/Validation
SOP No. SOP/Ointment/122
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the process for testing residue levels after cleaning in ointment manufacturing. This ensures that cleaning procedures effectively remove residues and comply with regulatory requirements.

2. Scope

This SOP applies to all personnel in the Quality Control (QC), Quality Assurance (QA), and Validation departments responsible for conducting residue level testing and ensuring compliance.

3. Responsibilities

  • QC Analyst: Conducts residue analysis and documents test results.
  • QA Officer: Reviews test results and ensures compliance with acceptance criteria.
  • Validation Team: Develops and approves residue testing methods.
  • Production Supervisor: Ensures adherence to validated cleaning procedures.
  • QA Manager: Approves residue testing protocols and reports.
See also  Ointments: SOP for Conducting CIP (Clean in Place) in Machines - V 2.0

4. Accountability

The QA and QC Managers are accountable for ensuring that residue testing is conducted as per GMP, FDA, ICH, and WHO guidelines.

5. Procedure

5.1 Selection of Residue Testing Methods

  • Choose appropriate residue testing methods based on:
    • Nature of the cleaning agents used
    • Characteristics of residual materials
    • Regulatory requirements and acceptance criteria
  • Common residue testing methods include:
    • Swab Sampling Method
    • Rinse Sampling Method
    • Total Organic Carbon (TOC) Analysis
    • High-Performance Liquid Chromatography (HPLC)
    • Visual Inspection

5.2 Preparation for

Residue Testing
  • Ensure that all test equipment is calibrated before use.
  • Prepare test reagents and standards as per validated protocols.
  • Assign trained personnel to conduct residue testing.

5.3 Execution of Residue Testing

5.3.1 Swab Sampling Method

  • Use sterile swabs to collect samples from designated equipment surfaces.
  • Swab a predefined surface area in a systematic pattern.
  • Place swabs in sterile vials and transport them to the laboratory for analysis.

5.3.2 Rinse Sampling Method

  • Collect rinse water samples from equipment after cleaning.
  • Ensure sample volumes meet minimum testing requirements.
  • Transport samples under controlled conditions to the laboratory.

5.3.3 Analytical Testing

  • Perform analytical testing using methods such as:
    • HPLC for active pharmaceutical ingredient (API) residue detection
    • TOC analysis for detecting organic residues
    • pH testing for confirming removal of acidic or alkaline cleaning agents
  • Record and analyze test results to determine compliance.

5.4 Acceptance Criteria and Compliance

  • Compare test results against predefined acceptance limits.
  • Residue levels must meet established criteria to ensure equipment cleanliness.
  • Document deviations and implement corrective actions if required.

5.5 Documentation and Review

  • Record test results in the Residue Testing Log.
  • QA must review and approve test results before equipment release.
  • Maintain records for regulatory audits.

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • QC – Quality Control
  • HPLC – High-Performance Liquid Chromatography
  • TOC – Total Organic Carbon

7. Documents

  • Residue Testing Protocol (Annexure-1)
  • Residue Testing Log (Annexure-2)

8. References

  • ICH Q7 – Good Manufacturing Practice Guide
  • WHO Guidelines for Residue Testing
  • US FDA Guidance on Cleaning Validation

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Residue Testing Protocol

Test Parameter Method Acceptance Criteria
API Residue HPLC < 10 ppm
Organic Residue TOC Analysis < 5 ppm
Cleaning Agent Residue pH Test Neutral

Annexure-2: Residue Testing Log

Date Equipment ID Sample Type Test Performed Result Reviewed By
01/02/2025 MIX-1001 Swab HPLC Pass QA Manager
02/02/2025 FILL-2002 Rinse TOC Pass QA Manager

12. Revision History:

Revision Date Revision No. Details of Revision Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: Tablets: SOP for Compression Weight Control During Tablet Manufacturing – V 2.0
Next Post: SOP for FIFO and FEFO Implementation in Raw Material Storage – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version